|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| A61P 9/10 | |||
| C07K 16/40 |
| (11) | Patento numeris | 3003361 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14733889.1 |
| Europos patento paraiškos padavimo data | 2014-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/040163 |
| Data | 2014-05-30 |
| (87) | Numeris | WO 2014/194168 |
| Data | 2014-12-04 |
| (30) | Numeris | Data | Šalis |
| 201361828753 P | 2013-05-30 | US | |
| 201361901705 P | 2013-11-08 | US | |
| 201361919836 P | 2013-12-23 | US | |
| 201461935358 P | 2014-02-04 | US | |
| 201461953959 P | 2014-03-17 | US | |
| 201461991738 P | 2014-05-12 | US | |
| 201414290544 | 2014-05-29 | US |
| (72) |
SWERGOLD, Gary, US
SASIELA, William, J., US
PORDY, Robert, C., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |